ACM
KPRX icon

ADAR1 Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History

ADAR1 Capital Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$324K Hold
167,941
– – 0.02% 234
2025
Q4 		$331K Hold
167,941
– – 0.02% 207
2025
Q3 		$467K Buy
167,941
+830
+0.5% +$2.28K 0.04% 141
2025
Q2 		$481K Sell
167,111
-27,554
-14% -$84K 0.07% 121
2025
Q1 		$586K Sell
194,665
-5,556
-3% -$19.3K 0.11% 98
2024
Q4 		$661K Buy
200,221
+3,670
+2% +$12.7K 0.13% 102
2024
Q3 		$719K Buy
196,551
+23,955
+14% +$93.5K 0.12% 97
2024
Q2 		$725K Buy
172,596
+50,374
+41% +$235K 0.14% 79
2024
Q1 		$777K Buy
+122,222
New +$683K 0.18% 70

Other funds holding KPRX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return